Victor J. DeNoble
|This article is a stub. You can help by expanding it.|
Victor J. DeNoble, Ph.D. was employed by Philip Morris in the Behavioral Research Department from 1980-1984. He was Associate Senior Scientist at Philip Morris Behavioral Research. He performed in-house Philip Morris rat studies on nicotine and addiction and was later fired by Philip Morris because of sensitive nature of what studies revealed about nicotine addiction.
Dr. DeNoble received his Doctorate degree in 1976 in Experimental Psychology from Adelphi University in Garden City, New York. He has performed postdoctoral fellowships from the National Institute of Alcohol and Alcohol Abuse at Downstate Medical Center in Brooklyn, New York and the National institute of Drug Abuse at the University of Minnesota. Dr. Denoble also worked in drug discovery for DuPont Merck Pharmaceutical Company and Ayerst Research Laboratories specializing in the area of Central Nervous System Diseases. Currently, Dr. DeNoble is the Vice President of Hissho, Inc., a scentific and medical communications company.
In 1994, after the U.S. Congress released him from a confidentiality agreement with Philip Morris, Dr. DeNoble became the first "Whistleblower" to begin speaking out against the tobacco industry. He served as a key witness in the Federal government's case against the industry and has testifed before Congress, the Food and Drug Administration and former Vice President Al Gore's Tobacco Settlement Committee. He has been featured on several television shows such as "60 Minutes," "Dateline NBC" and Sunday Morning with David Brinkley.
Dr. DeNoble worked with William Anthony Farone ("Bill Farone") at Philip Morris. He was hired to design a nicotine analogue that would retain the drug's addictive qualities while not affecting the function of the heart.
(Information taken from Dr. DeNoble's biosketch, not available online.) <tdo>resource_id=2724 resource_code=denoble_victor search_term=Victor J. DeNoble</tdo>